麒麟信安(688152.SH):持續鞏固並強化核心產品在安全辦公、航天測發控等關鍵業務場景的應用
格隆匯7月3日丨麒麟信安(688152.SH)在投資者互動平臺表示,公司基於多年來對特種行業用戶需求的深耕和研發投入,不斷對產品進行迭代創新發展,已在特種行業構建了一定的產品資質和行業生態壁壘。隨着特種領域國產化建設工作的全面鋪開,公司將充分發揮“操作系統+雲計算+信息安全”的整體方案優勢,積極佈局人工智能領域,持續鞏固並強化核心產品在安全辦公、航天測發控等關鍵業務場景的應用,推動實現產品的協同銷售增長。具體業績情況請您關注公司後續披露的定期報告。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.